BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 18979309)

  • 1. Development and characterization of self-microemulsifying drug delivery system of tacrolimus for intravenous administration.
    Borhade VB; Nair HA; Hegde DD
    Drug Dev Ind Pharm; 2009 May; 35(5):619-30. PubMed ID: 18979309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.
    Cui SX; Nie SF; Li L; Wang CG; Pan WS; Sun JP
    Drug Dev Ind Pharm; 2009 May; 35(5):603-11. PubMed ID: 19040178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides.
    Djekic L; Primorac M
    Int J Pharm; 2008 Mar; 352(1-2):231-9. PubMed ID: 18068919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus.
    Borhade V; Nair H; Hegde D
    AAPS PharmSciTech; 2008; 9(1):13-21. PubMed ID: 18446456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oleic acid based heterolipid synthesis, characterization and application in self-microemulsifying drug delivery system.
    Kalhapure RS; Akamanchi KG
    Int J Pharm; 2012 Apr; 425(1-2):9-18. PubMed ID: 22266534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems.
    Wang Y; Sun J; Zhang T; Liu H; He F; He Z
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1225-30. PubMed ID: 21615281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis.
    Nornoo AO; Osborne DW; Chow DS
    Int J Pharm; 2008 Feb; 349(1-2):108-16. PubMed ID: 17869459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
    Cirri M; Mura P; Mora PC
    Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.
    Balakrishnan P; Lee BJ; Oh DH; Kim JO; Lee YI; Kim DD; Jee JP; Lee YB; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2009 Jun; 374(1-2):66-72. PubMed ID: 19446761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
    Grove M; Müllertz A; Nielsen JL; Pedersen GP
    Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.
    Shen H; Zhong M
    J Pharm Pharmacol; 2006 Sep; 58(9):1183-91. PubMed ID: 16945176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a self-microemulsifying drug delivery system of tacrolimus.
    von Suesskind-Schwendi M; Gruber M; Touraud D; Kunz W; Schmid C; Hirt SW; Lehle K
    Biomed Pharmacother; 2013 Jul; 67(6):469-73. PubMed ID: 23669280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of SMEDDS using natural lipophile: application to beta-Artemether delivery.
    Mandawgade SD; Sharma S; Pathak S; Patravale VB
    Int J Pharm; 2008 Oct; 362(1-2):179-83. PubMed ID: 18652886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
    Cui J; Yu B; Zhao Y; Zhu W; Li H; Lou H; Zhai G
    Int J Pharm; 2009 Apr; 371(1-2):148-55. PubMed ID: 19124065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats.
    Setthacheewakul S; Mahattanadul S; Phadoongsombut N; Pichayakorn W; Wiwattanapatapee R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):475-85. PubMed ID: 20659556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice.
    Lu JL; Wang JC; Zhao SX; Liu XY; Zhao H; Zhang X; Zhou SF; Zhang Q
    Eur J Pharm Biopharm; 2008 Aug; 69(3):899-907. PubMed ID: 18434109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.
    Djekic L; Primorac M; Filipic S; Agbaba D
    Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin.
    Zhang P; Liu Y; Feng N; Xu J
    Int J Pharm; 2008 May; 355(1-2):269-76. PubMed ID: 18242895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput formulation screening system for self-microemulsifying drug delivery.
    Sakai K; Maeda H; Yoshimori T; Obata K; Ogawa Y
    Drug Dev Ind Pharm; 2009 Jun; 35(6):746-55. PubMed ID: 19514991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions.
    Li P; Ghosh A; Wagner RF; Krill S; Joshi YM; Serajuddin AT
    Int J Pharm; 2005 Jan; 288(1):27-34. PubMed ID: 15607255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.